From inception, Solbari has worked with ARPANSA, the Australian Government agency responsible for UPF testing and rating. UPF stands for ultraviolet protection factor and is the global standard for sun protective fabrics.
The Australian Government formalised the UPF fabric testing regime in the 1990s. Other countries followed suit, but Australia remains the global leader in UPF sun protective clothing, skin cancer prevention, diagnosis and treatment.
UPF 50+ is the highest sun protective rating in the World. UPF 50+ means that only up to 2% or 1/50th of UV radiation can penetrate the fabric.
Johanna Young, Founder of Solbari Sun Protection commented “it is of paramount importance for us as Australia’s leading specialist UPF 50+ sun protective clothing brand for our clothing to be accredited with the highest achievable UPF rating”.
She added, “our community place a lot of trust in us to make sure our fabrics are rigorously and independently tested for their sun protective attributes”
Solbari Sun Protection is the leading specialist Australian sun protection clothing brand with customers in over 70 countries. Solbari sun protective range includes UPF 50+ clothing, UV arm sleeves, broad brim sun hats and sun umbrellas.
You can find out more about Solbari's certified UPF50+ sun protective range by clicking the blue links below:
Sun hats UPF50+
The Solbari Team
This blog is for information purposes only, always consult your medical professional.
We understand that getting an appointment with a dermatologist or skin doctor can be challenging and expensive.
We decided it would be great to bring the best early skin cancer detection technology direct to the Solbari global community.
Skin Cancer rates increase 150% in UK
Cancer Research UK announced this week that skin cancer incidence rates in the UK have increased markedly.
The introduction of “lockdowns”, the restriction of movement and non-essential healthcare activities being suspended have had an impact on the diagnosis of cancer cases including skin cancer.
Countries around the World are now evaluating the unintended consequences of Covid-19 restrictions on the diagnosis of cancer. Sadly, cancer related death rates are expected to increase over the coming years due to the delay in diagnosis.